# US 2023/0067422 A1 · Aminoalkanoic acid derivative containing biphenyl group and use of the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0067422 A1
- Document ID: US20230067422A1
- Status: Published application
- Kind: A1
- Application number: 17/948,162
- Filed: 2022-09-19
- Published: 2023-03-02
- Earliest claimed: 2019-06-25
- Assignees: Amtixbio Co., Ltd.
- Applicants: Amtixbio Co., Ltd.
- Inventors: Ki Duk PARK; Jong Hyun PARK; Hyeon Ji KIM; Ye Rim LEE; Siwon KIM; Ji Won CHOI; Seul Ki YEON; Jong-Seung LEE; Yong-Sun BAHN; Eunji CHEONG; Kyung-Tae LEE; Joohyeon HONG
- Web page: https://patentgrep.com/patent/US20230067422A1

## CPC

- C07C 231/02: from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
- C07C 237/20: the carbon skeleton containing six-membered aromatic rings
- A61P 31/10: Antimycotics
- A61K 31/165: having aromatic rings, e.g. colchicine, atenolol, progabide
- Y02P 20/55: Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

The present invention relates to a derivative compound in which a biphenyl group is introduced into an aminoalkanoic acid, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound of the present invention exhibits excellent antifungal and fungicidal effects. Furthermore, the compound of the present invention exhibits a synergistic effect when used in combination with a conventional antifungal agent. Furthermore, the compound of the present invention provides broad-spectrum antifungal activity against a wide range of fungal pathogens. Therefore, the compound of the present invention may be widely used in fields requiring treatment with antifungal or fungicidal agents against human pathogenic fungi and animal pathogenic fungi, and phytopathogenic fungi.

## Claims

### Claim 1

A compound represented by the following Chemical Formula 1, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof:
in Formula 1,
n is 0, 1, 2, 3, 4 or 5,
R1, R2 and R3 are each independently the same as or different from each other, and are each independently selected from hydrogen, a C1-7 alkyl, a C3-6 cycloalkyl, hydroxyl, a halogen, a halogenated C1-7 alkyl, a C1-7 alkyloxy and a halogenated C1-7 alkyloxy, and
X is m substituents (m is an integer from 1 to 5) which are the same as or different from each other, selected from the group consisting of a halogen group, a halogenated C1-7 alkyl group and a halogenated C1-7 alkoxy group.

### Claim 2 (depends on 1)

The compound, the stereoisomer thereof, or the pharmaceutically acceptable salt thereof of claim 1,
wherein R1 and R2 are each independently H or methyl, ethyl, n-propyl, isopropyl, cyclopropyl, n-butyl, isobutyl, cyclobutyl, n-pentyl, cyclopentyl, n-hexyl or cyclohexyl, and
R3 is methyl, ethyl, n-propyl, isopropyl, cyclopropyl, n-butyl, isobutyl, sec-butyl or tert-butyl.

### Claim 3 (depends on 1)

The compound, the stereoisomer thereof, or the pharmaceutically acceptable salt thereof of claim 1, wherein X is any one or two identical or different substituents selected from the group consisting of fluoro, chloro, trifluoromethyl and trifluoromethoxy.

### Claim 4 (depends on 3)

The compound, the stereoisomer thereof, or the pharmaceutically acceptable salt thereof of claim 3, wherein X is p-fluoro, m-fluoro, p,m-difluoro, p-chloro, m-chloro, p,m-dichloro, p-trifluoromethyl or p-trifluoromethoxy.

### Claim 5 (depends on 1)

An antifungal composition comprising, as an active ingredient, the compound, the stereoisomer thereof, or the pharmaceutically acceptable salt thereof of claim 1.

### Claim 6 (depends on 5)

The antifungal composition of claim 5, wherein the antifungal composition exhibits antifungal activity against Cryptococcus neoformans, Candida albicans, Candida glabrata, or Aspergillus fumigatus.

### Claim 7 (depends on 1)

A pharmaceutical composition for treating or preventing a fungal infectious disease, comprising, as an active ingredient, the compound, the stereoisomer thereof, or the pharmaceutically acceptable salt thereof of claim 1.

### Claim 8 (depends on 7)

The pharmaceutical composition of claim 7, wherein the fungal infectious disease is caused by infections of Cryptococcus neoformans, Candida albicans, Candida glabrata, or Aspergillus fumigatus.

### Claim 9 (depends on 7)

The pharmaceutical composition of claim 7, further comprising a pharmaceutically acceptable carrier, diluent or excipient.

### Claim 10 (depends on 1)

An antibacterial composition comprising, as an active ingredient, the compound, the stereoisomer thereof, or the pharmaceutically acceptable salt thereof of claim 1.

### Claim 11 (depends on 10)

The antibacterial composition of claim 10, wherein the antibacterial composition exhibits antibacterial activity against Gram-negative bacteria, Gram-positive bacteria, or multi-drug resistant bacteria.

### Claim 12 (depends on 1)

A pharmaceutical composition for treating or preventing a bacterial infectious disease, comprising, as an active ingredient, the compound, the stereoisomer thereof, or the pharmaceutically acceptable salt thereof of claim 1.

### Claim 13 (depends on 1)

A pharmaceutical composition for treating or preventing an anti-inflammatory disease, comprising the compound, the stereoisomer thereof, or the pharmaceutically acceptable salt thereof of claim 1, and a pharmaceutically acceptable carrier, diluent or excipient.
